146 related articles for article (PubMed ID: 37153541)
21. Prognostic Impact of Immune-Related Gene Expression in Preoperative Peripheral Blood from Gastric Cancer Patients.
Ito S; Fukagawa T; Noda M; Hu Q; Nambara S; Shimizu D; Kuroda Y; Eguchi H; Masuda T; Sato T; Katai H; Sasako M; Mimori K
Ann Surg Oncol; 2018 Nov; 25(12):3755-3763. PubMed ID: 30203407
[TBL] [Abstract][Full Text] [Related]
22. Effect of IL-10-producing B cells in peripheral blood and tumor tissue on gastric cancer.
Jung YJ; Woo JS; Hwang SH; Yang S; Kim SJ; Jhun J; Lee SY; Lee KH; Cho ML; Song KY
Cell Commun Signal; 2023 Nov; 21(1):320. PubMed ID: 37946227
[TBL] [Abstract][Full Text] [Related]
23. Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer Prognosis.
Fan Y; Che X; Qu J; Hou K; Wen T; Li Z; Li C; Wang S; Xu L; Liu Y; Qu X
Ann Surg Oncol; 2019 Oct; 26(11):3745-3755. PubMed ID: 31087180
[TBL] [Abstract][Full Text] [Related]
24. Programmed death-ligand 1 expression in gastric adenocarcinoma is a poor prognostic factor in a high CD8+ tumor infiltrating lymphocytes group.
Chang H; Jung WY; Kang Y; Lee H; Kim A; Kim HK; Shin BK; Kim BH
Oncotarget; 2016 Dec; 7(49):80426-80434. PubMed ID: 27741514
[TBL] [Abstract][Full Text] [Related]
25. Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression.
Saito H; Kono Y; Murakami Y; Shishido Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
Anticancer Res; 2018 Jan; 38(1):107-112. PubMed ID: 29277762
[TBL] [Abstract][Full Text] [Related]
26. Short telomere length in peripheral blood leukocyte predicts poor prognosis and indicates an immunosuppressive phenotype in gastric cancer patients.
Qu F; Li R; He X; Li Q; Xie S; Gong L; Ji G; Lu J; Bao G
Mol Oncol; 2015 Mar; 9(3):727-39. PubMed ID: 25515040
[TBL] [Abstract][Full Text] [Related]
27. Association Between Intra-Tumoral Immune Response and Programmed Death Ligand 1 (PD-L1) in Gastric Cancer.
Yan R; Yang X; Wang X; Wang B; Zhao Y; Huang W; Zhao W; Jia L
Med Sci Monit; 2019 Sep; 25():6916-6921. PubMed ID: 31519868
[TBL] [Abstract][Full Text] [Related]
28. PD-L1 Expression Is a Favorable Prognostic Marker in Gastric Carcinoma.
Sughayer MA; Dabbagh TZ; Battah AH
Appl Immunohistochem Mol Morphol; 2020; 28(10):748-754. PubMed ID: 32205740
[TBL] [Abstract][Full Text] [Related]
29. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY
Front Immunol; 2021; 12():705378. PubMed ID: 34526987
[TBL] [Abstract][Full Text] [Related]
30. Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer.
Yamashita K; Iwatsuki M; Yasuda-Yoshihara N; Morinaga T; Nakao Y; Harada K; Eto K; Kurashige J; Hiyoshi Y; Ishimoto T; Nagai Y; Iwagami S; Baba Y; Miyamoto Y; Yoshida N; Ajani JA; Baba H
Br J Cancer; 2021 Feb; 124(3):595-603. PubMed ID: 33100329
[TBL] [Abstract][Full Text] [Related]
31. Association of PD-1, PD-L1, and CTLA-4 Gene Expression and Clinicopathologic Characteristics in Patients With Non-Small-Cell Lung Cancer.
Lafuente-Sanchis A; Zúñiga Á; Estors M; Martínez-Hernández NJ; Cremades A; Cuenca M; Galbis JM
Clin Lung Cancer; 2017 Mar; 18(2):e109-e116. PubMed ID: 27816393
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of PD-L1 Immunohistochemical Marker in Gastric Carcinoma and Its Correlation with HER2 Status.
Attia S; Abd El Hafez A; Abdel-Aziz A; Elmetwaly S; Mokhtar N
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1433-1444. PubMed ID: 35485706
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer.
Shi J; Yang X; Wang X; Luo Y; Zhou W; Luo H; Bianba Z; Nima Z; Wang Q; Wang H; Liao R; Ciren Q; Li M; Pang J
Biomed Res Int; 2022; 2022():2684065. PubMed ID: 35734348
[TBL] [Abstract][Full Text] [Related]
35. MiR-21 Participates in the PD-1/PD-L1 Pathway-Mediated Imbalance of Th17/Treg Cells in Patients After Gastric Cancer Resection.
Zheng X; Dong L; Wang K; Zou H; Zhao S; Wang Y; Wang G
Ann Surg Oncol; 2019 Mar; 26(3):884-893. PubMed ID: 30565043
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of interleukin-2 production by bovine peripheral blood mononuclear cells treated with the combination of anti-programmed death-ligand 1 and cytotoxic T lymphocyte antigen 4 chimeric monoclonal antibodies.
Watari K; Konnai S; Okagawa T; Maekawa N; Sajiki Y; Kato Y; Suzuki Y; Murata S; Ohashi K
J Vet Med Sci; 2022 Jan; 84(1):6-15. PubMed ID: 34789592
[TBL] [Abstract][Full Text] [Related]
37. Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer.
Wu Y; Zhao T; Jia Z; Cao D; Cao X; Pan Y; Zhao D; Zhang B; Jiang J
J Gastroenterol Hepatol; 2019 Jul; 34(7):1201-1207. PubMed ID: 30353572
[TBL] [Abstract][Full Text] [Related]
38. A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer.
Wen T; Wang Z; Li Y; Li Z; Che X; Fan Y; Wang S; Qu J; Yang X; Hou K; Zhou W; Xu L; Li C; Wang J; Liu J; Chen L; Zhang J; Qu X; Liu Y
Cancer Immunol Res; 2017 Jul; 5(7):524-534. PubMed ID: 28619967
[TBL] [Abstract][Full Text] [Related]
39. Programmed cell death protein 1 expression is an independent prognostic factor in gastric cancer after curative resection.
Eto S; Yoshikawa K; Nishi M; Higashijima J; Tokunaga T; Nakao T; Kashihara H; Takasu C; Iwata T; Shimada M
Gastric Cancer; 2016 Apr; 19(2):466-471. PubMed ID: 26210691
[TBL] [Abstract][Full Text] [Related]
40. Understanding immune phenotypes in human gastric disease tissues by multiplexed immunohistochemistry.
Ying L; Yan F; Meng Q; Yuan X; Yu L; Williams BRG; Chan DW; Shi L; Tu Y; Ni P; Wang X; Xu D; Hu Y
J Transl Med; 2017 Oct; 15(1):206. PubMed ID: 29025424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
